Document is current
Any future updates will be listed below
-
Authors
Heidenreich, Sebastian https://orcid.org/0000-0002-1909-5770
Phillips-Beyer, Andrea https://orcid.org/0000-0003-3927-4319
Flamion, Bruno
Ross, Melissa
Seo, Jaein
Marsh, Kevin https://orcid.org/0000-0002-7912-9485
-
Funding
Funding for this research was provided by:
Idorsia Pharmaceuticals Ltd.
- License Information
-
More Information
Article History
Accepted: 15 October 2020
First Online: 11 November 2020
Declarations
:
: This work was funded by Idorsia Pharmaceuticals Ltd. The views expressed are those of the authors and not necessarily those of Idorsia Pharmaceuticals Ltd. No funding was received for the development of this manuscript.
: Bruno Flamion is an employee and minor stock holder of Idorsia Pharmaceuticals Ltd, the study sponsor. Innovus Consulting Ltd and Evidera Inc. received funding for the work that is described in this manuscript. Sebastian Heidenreich, Kevin Marsh, Melissa Ross, and Jaein Seo are employees of Evidera Inc. Andrea Phillips-Beyer is an employee of Innovus Consulting Ltd.
: All participants gave informed consent before completing the survey.
: Ethical approval for this study was obtained on 4 April 2018 from Ethics and Independent Review Services (E&I IRB #2–IRB00007807; study number: 18044-01), who reviewed the study protocol and all patient-facing material, including the informed consent forms.
